kentucky tirzepatide class action Zepbound Lawsuit [2026] Can you take tirzepatide every

His testosterone comes back at 280 ng/dL, which is below the normal range

SURPASS-2 trial confirmed that gastrointestinal adverse events with tirzepatide were consistent with the GLP-1 receptor agonist class, mostly mild to moderate, and occurred during the escalation period with both tirzepatide and the comparator drug semaglutide

Here is what the trial showed and what route of administration actually changes

goal 23 semisoft stools per day) plus albumin (1.5 g/kg/day) or lactulose alone, and treatment was continued until recovery of HE or for a maximum of 10 days

Retatrutide 30MG adds glucagon receptor agonism as a third target